HTC
EDIT icon

Hershey Trust Company’s Editas Medicine EDIT Stock Holding History

Hershey Trust Company’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-14,545
Closed -$244K – 14
2017
Q2 		$244K Buy
+14,545
New +$262K ﹤0.01% 11
2017
Q1 		– Sell
-7,273
Closed -$118K – 14
2016
Q4 		$118K Hold
7,273
– – ﹤0.01% 14
2016
Q3 		$98K Buy
+7,273
New +$149K ﹤0.01% 10

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hershey Trust Company's EDIT Position: Q3 2017 in Review

Hershey Trust Company sold out of Editas Medicine (EDIT) in Q3 2017, closing a stake of 14,545 shares — an estimated $244K sold.

Hershey Trust Company first reported a position in EDIT in Q3 2016 and held it in 3 quarters. The position peaked at $244K in Q2 2017. 116 funds tracked by Wall St. Rank hold EDIT as of Q3 2017.

  • Hershey Trust Company reported no remaining Editas Medicine position as of Q3 2017 after selling out during the quarter.
  • Hershey Trust Company sold 14,545 Editas Medicine shares in Q3 2017, an estimated $244K.
  • Hershey Trust Company first reported a position in Editas Medicine in Q3 2016 and held it in 3 quarters.
  • Hershey Trust Company's Editas Medicine position peaked at $244K in Q2 2017.
  • 116 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2017.

Based on Hershey Trust Company's 13F filing for Q3 2017, filed 24 Oct 2017.